Search For
/
Stocks
Intraday Booster
Sector Booster
Stock Screener
Market Pulse
Screeners
More
Go Prime
My Plans
Privacy Policy
Contact
Refer & EarnScreenersMain
Stock Screener
Create Screener
Explore Screeners
Community ScreenersTrading Screeners
CandleSticks Screener
Top Gainers & Losers
Opening Range Breakout
Stock Screener AI
Stock Quality Scorecard
Overvalued StocksNewUndervalued StocksNewTechnical Screeners
NR4 Stocks
NR7 Stocks
Previous Day High Breakout
Previous Day Low Breakout
Previous Day Open Breakout
Bullish Crossover Stocks
Bearish Crossover Stocks
High Volume Shocker
VWAP Breakout Stocks
Range High Breakout
Range Low BreakoutMoreMarkets
Global Market Today
Global Indices
Indian Indices
NIfty TodaySmart Money
FII DII DataNew
FII Buying
NSE Insider Trading
SLB Stocks DataDerivatives
FnO Movements
NSE F&O Lot Size
Ban ListAnalysis & Calendars
Technical DashboardSector Booster
Sector AnalysisNew
Result Calendar
Economic Calendar
Price Chart
Compare with Peers
Historical Ratios
Track top 12 most important financial ratios
P/E Ratio: Price to Earnings - Most used valuation metric
Loading chart...
Analyzing Investment Quality
Processing 9 key metrics...
Key Metrics
Hover for details
Valuation
Market Cap
₹455.82 Cr
Market Cap
Total market value of companyP/E Ratio
17.63
P/E Ratio
Price to Earnings. Lower is generally better (<25 is good)P/B Ratio
5.92
P/B Ratio
Price to Book Value. <3 may indicate undervaluationEPS
₹6.90
EPS
Earnings Per Share. Higher and growing is positiveProfitability
ROE
-%
ROE
Return on Equity. >15% is good, >20% is excellentROCE
43.80%
ROCE
Return on Capital Employed. >15% is goodNet Margin
25.78%
Net Margin
Net profit as % of revenue. >10% is goodOperating Margin
-%
Operating Margin
Operating profit margin. >15% is goodGrowth
EPS Growth (5Y)
-%
EPS Growth (5Y)
5-year EPS growth. >15% is strongRevenue Growth (5Y)
-%
Revenue Growth (5Y)
5-year revenue growth. >10% is goodQtr Sales Growth
-3.57%
Qtr Sales Growth
Quarter-over-quarter sales growthQtr Profit Growth
2.11%
Qtr Profit Growth
Quarter-over-quarter profit growthFinancial Health
Debt/Equity
-
Debt/Equity
Financial leverage. <1 is good, <0.5 is excellentBook Value
₹24.28
Book Value
Net asset value per shareDividend Yield
-%
Dividend Yield
Annual dividend as % of price. >2% is goodPromoter Holding
74.20%
Promoter Holding
Promoter stake. >50% shows confidenceGood
Average
Needs Attention
SWOT Analysis
Strengths
5 points- •Kronox Lab Sciences demonstrates exceptional profitability with a high Return on Capital Employed (ROCE) of 43.80% and Return on Equity (ROE) of 32.60%, significantly outperforming many industry benchmarks.
- •The company maintains a robust financial structure, being completely debt-free with a 0.00 debt-to-equity ratio, providing strong financial stability and flexibility for future growth initiatives.
Weaknesses
4 points- •A notable decline in FII holdings from 1.56% to 0.03% and DII holdings from 4.34% to 1.93% over the past year indicates a decreasing institutional investor interest in the company.
- •The company experienced a negative quarterly sales growth of -3.57%, suggesting a potential slowdown in revenue generation and raising concerns about short-term top-line performance.
Opportunities
3 points- •Operating in the 'Specialty Chemicals' sector, Kronox is well-positioned to capitalize on the industry's robust growth trends and increasing demand for specialized chemical products globally.
- •The company's significantly lower P/E ratio of 21.90 compared to the sector average (26.41) and peers presents a potential re-rating opportunity as its growth story unfolds.
Threats
3 points- •Kronox faces intense competition from larger, more established players in the Specialty Chemicals sector, which could impact market share and pricing power in the long run.
- •The company's stock has experienced significant volatility, trading far below its 52-week high, indicating susceptibility to broader market sentiment and potential investor uncertainty.
Segment-wise Financial Analysis
Financial Results
Balance Sheet
Standalone • Annual • All amounts in ₹ Crores • CA Schedule III Format
No Balance Sheet Data Available
Standalone annual data is not available for this symbol.
Try switching to Consolidated view.
Shareholding Pattern
Loading shareholding data...
Company Insider Trading Activity
No insider trading data available
Corporate Action
Company Announcements
Technical Analysis & Indicators
Standard pivot points - most widely used
Pivot Points (CLASSIC)
| Level | Price | Distance | % Change |
|---|---|---|---|
| R4 | ₹126.33 | +₹10.03 | +8.63% |
| R3 | ₹122.28 | +₹5.98 | +5.14% |
| R2 | ₹120.17 | +₹3.87 | +3.32% |
| R1 | ₹118.23 | +₹1.93 | +1.66% |
| PIVOT | ₹116.12 | -0.18 | -0.16% |
| CURRENT | ₹116.30 | - | - |
| S1 | ₹106.08 | -₹10.22 | -8.78% |
| S2 | ₹110.13 | -₹6.17 | -5.30% |
| S3 | ₹112.07 | -₹4.23 | -3.64% |
| S4 | ₹114.18 | -₹2.12 | -1.82% |
CPR Levels
Support
Resistance
S4
N/A
S3
N/A
S2
N/A
S1
N/A
| CPR |
BC: N/AP: N/ATC: N/A
R1
N/A
R2
N/A
R3
N/A
R4
N/A
LTP: N/A
PDH: N/A
PDL: N/A
● Market Sentiment
is trading CPR, indicating
● CPR Width
CPR is
● Opening Range
Day's range: ~
● Price Position
Trading Inside opening range
Delivery Volume Analysis & Trading Activity
Latest Volume+56.2% vs avg
0.64L
(02 Mar 2026)Delivery %-20.0% vs avg
37.4%
(02 Mar 2026)Avg Volume (20D)20-day average
0.41L
(03 Feb - 02 Mar)Avg Delivery %Trend ↓
57.3%
(03 Feb - 02 Mar)Delivery % indicates the percentage of traded volume that resulted in actual delivery. Higher delivery % (>50%) suggests genuine buying interest and stronger hands.
Peer Comparison & Industry Benchmarking
Quick Compare
Largest by Market Cap
Asian Paints Ltd
2.34L ₹ Cr
Best Profit Growth
Dynemic Products Ltd
73.00 %
Highest Dividend Yield
Plastiblends India Ltd
1.63 %
Peer Comparison
| Company Name |
|---|
 20 Microns Ltd |
 Asian Paints Ltd |
 |
 Chemcon Speciality Chemicals Ltd |
 DIC India Ltd |
 Dynemic Products Ltd |
 Ganesh Benzoplast Ltd |
 HP Adhesives Ltd |
 Plastiblends India Ltd |
 Shalimar Paints Ltd |
 Vikas Ecotech Ltd |
About
Kronox Lab Sciences Ltd
Kronox Lab Sciences Limited is a chemical manufacturing and distribution company operating in India and globally. Their core business centers around the production and sale of a wide range of chemicals, catering to various industrial sectors. This includes substantial volumes of fine chemicals, inorganic chemicals, phosphates, and metallic chemicals.
A significant portion of Kronox's business involves supplying bulk reagents. These reagents are categorized based on their purity levels, encompassing ACS reagents and those classified as LR, AR, and GR grades. This signifies a focus on supplying chemicals for various applications requiring diverse purity standards, ranging from basic laboratory use to more stringent requirements for specific industries.
Beyond bulk reagents, Kronox offers a comprehensive portfolio of bulk ingredients tailored for multiple sectors. This includes key components for oral care products, pharmaceutical preparations (pharmacopoeia grade), food and nutraceutical products, personal care and cosmetic items, and veterinary pharmaceuticals and animal health products. This diversification demonstrates their capacity to serve a broad spectrum of industries with specialized chemical requirements.
Further enhancing their product range, Kronox specializes in the manufacture of specialty chemicals. This segment incorporates a diverse array of compounds, including tartrates, citrates, hypophosphites, phosphates, hydroxides, EDTA and its derivatives, ultra-high-purity chemicals, and custom-synthesized chemicals formulated to meet specific customer specifications. The inclusion of anhydrous versions of certain chemicals highlights their capacity to provide specialized chemical forms suited for niche applications.
Established in 2008 and headquartered in Vadodara, India, Kronox has built a significant presence in the chemical industry through its diverse product portfolio and ability to cater to the varying needs of multiple sectors. Their focus on both bulk and specialty chemicals, coupled with their commitment to meeting stringent purity standards, solidifies their position within the Indian and international chemical markets.
COMPANY FACTS - KRONOX
Registered Address
Padra, Village: Dabhas, Block No. 284
Vadodara
GUJARAT
IN
Tel: 912662244088
Website:https://www.kronoxlabsciences.com/
Investor Relations:http://www.kronoxlabsciences.com/investors/
Company Details
Group: Materials
Sector: Materials
Industry: Chemicals
Exchange: NATIONAL STOCK EXCHANGE OF INDIA
Employees: 57
IPO Date: 10/06/2024
MANAGEMENT - KRONOX
Mr. Jogindersingh Jaswal
Managing Director, Executive Chairman of the Board
Mr. Samir Gadhiya
Chief Financial Officer
Mr. Nikhil Goswami
Compliance Officer, Company Secretary
Mr. Ketan Ramani
Whole Time Director
Mr. Pritesh Ramani
Whole Time Director
Mr. Vijaykumar Khatri
Production Manager
Mr. Vishalkumar Parmar
Quality Control Manager
Mr. Mehul Patel
Marketing Manager
Mr. Raj Shah
Purchase Manager
Mr. Chintan Tamboli
Account Executive
Mr. Devendra Thakkar
Human Resource Manager
Ms. Priya Yadav
Quality Assurance Manager
Investor Questions Answered
Kronox Lab Sciences Ltd (KRONOX) Stock FAQs
Get answers to the most common questions about Kronox Lab Sciences Ltd stock price, fundamentals, financial metrics, and investment analysis
The current share price of Kronox Lab Sciences Ltd (KRONOX) is ₹116.3. Today, the stock has declined by ₹3.53 (2.95%), trading in a range of ₹114 to ₹118.05. The stock opened at ₹118.05 with a trading volume of 63,776 shares.
Kronox Lab Sciences Ltd can be considered for long-term investment based on several factors. The company has a market capitalization of ₹455.82 crores, P/E ratio of 17.63, ROE of 0.00%, and ROCE of 43.80%. The dividend yield stands at 0.00%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
The 52-week high price of Kronox Lab Sciences Ltd (KRONOX) is ₹207.49, while the 52-week low is ₹111.1. Currently trading at ₹116.3, the stock is 5.4% away from its 52-week low and 43.9% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
Whether to buy Kronox Lab Sciences Ltd stock at ₹116.3 depends on multiple factors. The stock is currently trading with a P/E ratio of 17.63 and P/B ratio of N/A. Today's performance shows a loss of 2.95%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
Kronox Lab Sciences Ltd offers a dividend yield of 0.00%, which means for every ₹100 invested at the current price of ₹116.3, you can expect to receive approximately ₹0.00 annually as dividends. The face value of the stock is ₹10.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
Kronox Lab Sciences Ltd's key financial metrics include: P/E Ratio: 17.63, P/B Ratio: N/A, ROE: 0.00%, ROCE: 43.80%, Dividend Yield: 0.00%, EPS: ₹6.90, Book Value: ₹24.28, Debt-to-Equity: 0.00, and Current Ratio: N/A. The company's market cap stands at ₹455.82 crores. These metrics help evaluate the company's valuation, profitability, and financial health.
Kronox Lab Sciences Ltd stock opened at ₹118.05 and is currently trading at ₹116.3, showing a decline of ₹3.53 (2.95%). The intraday high is ₹118.05 and low is ₹114. The trading volume stands at 63,776 shares, indicating moderate market participation today.
Kronox Lab Sciences Ltd has a Price-to-Earnings (P/E) ratio of 17.63, which means investors are willing to pay ₹17.63 for every ₹1 of earnings. With an EPS of ₹6.90, this P/E ratio indicates moderate valuation in line with market standards. Compare this with industry peers and historical P/E ratios for better context.
Kronox Lab Sciences Ltd has a market capitalization of ₹455.82 crores, making it a small-cap company. Market cap is calculated by multiplying the current stock price (₹116.3) by the total number of outstanding shares. This metric helps investors understand the company's size, stability, and investment risk profile.
Kronox Lab Sciences Ltd has a book value of ₹24.28 per share and a Price-to-Book (P/B) ratio of N/A. The current market price is ₹116.3, which is 379.0% above the book value. A P/B ratio below 1 may indicate undervaluation or asset quality concerns.
Kronox Lab Sciences Ltd has a Return on Equity (ROE) of 0.00% and Return on Capital Employed (ROCE) of 43.80%. ROE measures how efficiently the company generates profits from shareholders' equity, while ROCE indicates how well the company uses its capital to generate profits. These returns may need improvement for better profitability. Higher percentages generally indicate better financial performance.
Kronox Lab Sciences Ltd operates in the diversified sector and belongs to the general industry. The company competes with other players in this space and its performance is influenced by sector-specific trends, regulatory changes, and market dynamics. Understanding the sector helps investors assess growth potential, cyclical patterns, and industry-specific risks that may impact the stock's performance.
Kronox Lab Sciences Ltd has a debt-to-equity ratio of 0.00, which measures the company's financial leverage by comparing total debt to shareholders' equity. A low ratio suggests conservative financing with minimal debt. Lower ratios generally indicate lower financial risk, but optimal levels vary by industry.
Kronox Lab Sciences Ltd has an Earnings Per Share (EPS) of ₹6.90, which represents the company's profit allocated to each outstanding share. With a current stock price of ₹116.3 and P/E ratio of 17.63, investors are paying 17.63 times the annual earnings per share. The company may need to improve its earnings performance. Track EPS growth over quarters to assess earnings momentum.
Kronox Lab Sciences Ltd has reported a sales growth of N/A% and profit growth of N/A%. The company may be facing growth challenges or operating in a mature market. Consistent growth over multiple quarters is a positive indicator for long-term investors. Compare these growth rates with industry peers for better perspective.
Kronox Lab Sciences Ltd has a current ratio of N/A, which measures the company's ability to pay short-term obligations with current assets. A ratio below 1 may indicate potential liquidity concerns. This metric is crucial for assessing the company's working capital management and financial safety.
To analyze Kronox Lab Sciences Ltd stock, consider: 1) Fundamental Analysis - Review P/E (17.63), ROE (0.00%), debt-to-equity (0.00), and growth rates. 2) Technical Analysis - Check 52-week range (₹111.10 - ₹207.49), moving averages, and chart patterns. 3) Valuation - Compare current price (₹116.30) with book value (₹24.28) and industry peers. 4) Financial Health - Assess current ratio (N/A) and cash flows. 5) Growth Prospects - Evaluate sales growth (N/A%) and profit growth (N/A%). Always diversify and consult a financial advisor.
The face value (or par value) of Kronox Lab Sciences Ltd share is ₹10.00. Face value is the nominal value of a share as stated in the company's charter and is used for accounting purposes and calculating dividends. The current market price of ₹116.3 is 1063x the face value. Face value remains constant unless the company undergoes a stock split or bonus issue, while market price fluctuates based on demand and supply.
Investing in Kronox Lab Sciences Ltd carries several risks: 1) Market Risk - Stock price volatility (52-week range: ₹111.10 - ₹207.49). 2) Business Risk - Industry-specific challenges in the sector. 3) Financial Risk - Debt-to-equity ratio of 0.00 indicates leverage. 4) Liquidity Risk - Based on trading volume of 63,776 shares. 5) Valuation Risk - P/E of 17.63 may indicate over/undervaluation. 6) Economic Risk - Macroeconomic factors affecting the industry. Diversify your portfolio and invest only what you can afford to lose.
Kronox Lab Sciences Ltd operates in the industry with key metrics: P/E ratio of 17.63, ROE of 0.00%, market cap of ₹455.82 crores, and dividend yield of 0.00%. To make an informed comparison, analyze these metrics against industry peers considering factors like revenue growth (N/A%), profit margins, debt levels (D/E: 0.00), and market position. Use our peer comparison tool on this page to see detailed side-by-side analysis with competitors.
Target prices for Kronox Lab Sciences Ltd vary among analysts and depend on multiple factors including earnings projections, industry trends, and market conditions. The stock is currently trading at ₹116.3, with a 52-week range of ₹111.10 to ₹207.49. Based on fundamentals like P/E (17.63), ROE (0.00%), and growth rates, analysts may have different target prices. Always refer to recent research reports from reputed brokerages and make decisions based on your own analysis and risk appetite.
Consider selling Kronox Lab Sciences Ltd stock when: 1) Target Price Achieved - If the stock reaches your predetermined target from current ₹116.30. 2) Fundamental Deterioration - Declining ROE (currently 0.00%), increasing debt (D/E: 0.00), or falling growth rates. 3) Better Opportunities - Finding stocks with superior risk-reward ratios. 4) Portfolio Rebalancing - When the stock becomes overweight in your portfolio. 5) Changed Investment Thesis - If reasons for buying no longer hold. 6) Stop Loss - If price falls below your risk threshold. Always base decisions on thorough analysis rather than emotions.
Tax implications for Kronox Lab Sciences Ltd stock investments: 1) Short-term Capital Gains (STCG) - If sold within 1 year, gains taxed at 15% plus cess. 2) Long-term Capital Gains (LTCG) - If held over 1 year, gains above ₹1 lakh taxed at 10% without indexation. 3) Dividend Income - Dividends (current yield: 0.00%) are taxable as per your income tax slab. 4) Securities Transaction Tax (STT) - Applicable on both buy and sell transactions. 5) Intraday Trading - Treated as speculative income, taxed as per slab. Tax laws change periodically, so consult a tax advisor for personalized guidance and latest regulations.
Menu